Global Adeno-Associated Virus (AAV) Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Adeno-Associated Virus (AAV) Gene Therapy market size is projected to grow from US$ 1601.4 million in 2022 to US$ 2951.7 million in 2029; it is expected to grow at a CAGR of 9.1% from 2023 to 2029.
United States market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adeno-Associated Virus (AAV) Gene Therapy players cover Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Adeno-Associated Virus (AAV) Gene Therapy Industry Forecast” looks at past sales and reviews total world Adeno-Associated Virus (AAV) Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adeno-Associated Virus (AAV) Gene Therapy sales for 2023 through 2029. With Adeno-Associated Virus (AAV) Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adeno-Associated Virus (AAV) Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adeno-Associated Virus (AAV) Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adeno-Associated Virus (AAV) Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adeno-Associated Virus (AAV) Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adeno-Associated Virus (AAV) Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adeno-Associated Virus (AAV) Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adeno-Associated Virus (AAV) Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Adeno-Associated Virus (AAV) Gene Therapy market size is projected to grow from US$ 1601.4 million in 2022 to US$ 2951.7 million in 2029; it is expected to grow at a CAGR of 9.1% from 2023 to 2029.
United States market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adeno-Associated Virus (AAV) Gene Therapy players cover Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Adeno-Associated Virus (AAV) Gene Therapy Industry Forecast” looks at past sales and reviews total world Adeno-Associated Virus (AAV) Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adeno-Associated Virus (AAV) Gene Therapy sales for 2023 through 2029. With Adeno-Associated Virus (AAV) Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adeno-Associated Virus (AAV) Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adeno-Associated Virus (AAV) Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adeno-Associated Virus (AAV) Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adeno-Associated Virus (AAV) Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adeno-Associated Virus (AAV) Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adeno-Associated Virus (AAV) Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adeno-Associated Virus (AAV) Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Luxturna
- Zolgensma
- Others
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Biolabs
- Affinia Therapeutics
- Spark Therapeutics
- AGC Biologics
- StrideBio
- SIRION Biotech
- Neurophth Biotechnology
- Belief BioMed
- BiBo Biopharma Engineering Co., LTD.
- Beihai Kangcheng
- PackGene Biotech
- Sarepta Therapeutics
- Carbon BioSciences
- Kelonia Therapeutics
- Roche
- Remedium Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2029
2.1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
2.2.1 Luxturna
2.2.2 Zolgensma
2.2.3 Others
2.3 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
2.3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
2.4.1 Central Nervous System Diseases
2.4.2 Ocular Diseases
2.4.3 Liver-directed Diseases
2.4.4 Other Hereditary Diseases
2.5 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
2.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
3 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Players
3.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY BY REGIONS
4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy by Country (2018-2023)
7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.2 Canada Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.3 Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.4 Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.2 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.3 Korea Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.4 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.5 India Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.6 Australia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.2 France Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.3 UK Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.4 Italy Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.5 Russia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.2 South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.3 Israel Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.4 Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.5 GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.6 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Type (2024-2029)
10.7 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., LTD.
11.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
11.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BiBo Biopharma Engineering Co., LTD. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., LTD. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2029
2.1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
2.2.1 Luxturna
2.2.2 Zolgensma
2.2.3 Others
2.3 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
2.3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
2.4.1 Central Nervous System Diseases
2.4.2 Ocular Diseases
2.4.3 Liver-directed Diseases
2.4.4 Other Hereditary Diseases
2.5 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
2.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
3 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Players
3.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY BY REGIONS
4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy by Country (2018-2023)
7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.2 Canada Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.3 Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.2.4 Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.2 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.3 Korea Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.4 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.5 India Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.6 Australia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.2 France Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.3 UK Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.4 Italy Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.4.5 Russia Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.2 South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.3 Israel Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.4 Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.5.5 GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.6 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Type (2024-2029)
10.7 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., LTD.
11.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
11.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BiBo Biopharma Engineering Co., LTD. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., LTD. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Luxturna
Table 3. Major Players of Zolgensma
Table 4. Major Players of Others
Table 5. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 8. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2018-2023)
Table 13. Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
Table 14. Adeno-Associated Virus (AAV) Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus (AAV) Gene Therapy
Table 46. Key Market Challenges & Risks of Adeno-Associated Virus (AAV) Gene Therapy
Table 47. Key Industry Trends of Adeno-Associated Virus (AAV) Gene Therapy
Table 48. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Creative Biolabs Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 53. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 54. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Creative Biolabs Main Business
Table 56. Creative Biolabs Latest Developments
Table 57. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 58. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 59. Affinia Therapeutics Main Business
Table 60. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Affinia Therapeutics Latest Developments
Table 62. Spark Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 63. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 64. Spark Therapeutics Main Business
Table 65. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Spark Therapeutics Latest Developments
Table 67. AGC Biologics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 68. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 69. AGC Biologics Main Business
Table 70. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. AGC Biologics Latest Developments
Table 72. StrideBio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 73. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 74. StrideBio Main Business
Table 75. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. StrideBio Latest Developments
Table 77. SIRION Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 78. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 79. SIRION Biotech Main Business
Table 80. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. SIRION Biotech Latest Developments
Table 82. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 83. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 84. Neurophth Biotechnology Main Business
Table 85. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Neurophth Biotechnology Latest Developments
Table 87. Belief BioMed Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 88. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 89. Belief BioMed Main Business
Table 90. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Belief BioMed Latest Developments
Table 92. BiBo Biopharma Engineering Co., LTD. Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 93. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 94. BiBo Biopharma Engineering Co., LTD. Main Business
Table 95. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. BiBo Biopharma Engineering Co., LTD. Latest Developments
Table 97. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 98. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 99. Beihai Kangcheng Main Business
Table 100. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Beihai Kangcheng Latest Developments
Table 102. PackGene Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 103. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 104. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. PackGene Biotech Main Business
Table 106. PackGene Biotech Latest Developments
Table 107. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 108. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 109. Sarepta Therapeutics Main Business
Table 110. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Sarepta Therapeutics Latest Developments
Table 112. Carbon BioSciences Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 113. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 114. Carbon BioSciences Main Business
Table 115. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Carbon BioSciences Latest Developments
Table 117. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 118. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 119. Kelonia Therapeutics Main Business
Table 120. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Kelonia Therapeutics Latest Developments
Table 122. Roche Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 123. Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 124. Roche Main Business
Table 125. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Roche Latest Developments
Table 127. Remedium Bio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 128. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 129. Remedium Bio Main Business
Table 130. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Remedium Bio Latest Developments
Table 1. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Luxturna
Table 3. Major Players of Zolgensma
Table 4. Major Players of Others
Table 5. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 8. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2018-2023)
Table 13. Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
Table 14. Adeno-Associated Virus (AAV) Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus (AAV) Gene Therapy
Table 46. Key Market Challenges & Risks of Adeno-Associated Virus (AAV) Gene Therapy
Table 47. Key Industry Trends of Adeno-Associated Virus (AAV) Gene Therapy
Table 48. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Creative Biolabs Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 53. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 54. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Creative Biolabs Main Business
Table 56. Creative Biolabs Latest Developments
Table 57. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 58. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 59. Affinia Therapeutics Main Business
Table 60. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Affinia Therapeutics Latest Developments
Table 62. Spark Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 63. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 64. Spark Therapeutics Main Business
Table 65. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Spark Therapeutics Latest Developments
Table 67. AGC Biologics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 68. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 69. AGC Biologics Main Business
Table 70. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. AGC Biologics Latest Developments
Table 72. StrideBio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 73. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 74. StrideBio Main Business
Table 75. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. StrideBio Latest Developments
Table 77. SIRION Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 78. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 79. SIRION Biotech Main Business
Table 80. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. SIRION Biotech Latest Developments
Table 82. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 83. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 84. Neurophth Biotechnology Main Business
Table 85. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Neurophth Biotechnology Latest Developments
Table 87. Belief BioMed Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 88. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 89. Belief BioMed Main Business
Table 90. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Belief BioMed Latest Developments
Table 92. BiBo Biopharma Engineering Co., LTD. Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 93. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 94. BiBo Biopharma Engineering Co., LTD. Main Business
Table 95. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. BiBo Biopharma Engineering Co., LTD. Latest Developments
Table 97. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 98. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 99. Beihai Kangcheng Main Business
Table 100. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Beihai Kangcheng Latest Developments
Table 102. PackGene Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 103. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 104. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. PackGene Biotech Main Business
Table 106. PackGene Biotech Latest Developments
Table 107. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 108. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 109. Sarepta Therapeutics Main Business
Table 110. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Sarepta Therapeutics Latest Developments
Table 112. Carbon BioSciences Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 113. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 114. Carbon BioSciences Main Business
Table 115. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Carbon BioSciences Latest Developments
Table 117. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 118. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 119. Kelonia Therapeutics Main Business
Table 120. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Kelonia Therapeutics Latest Developments
Table 122. Roche Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 123. Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 124. Roche Main Business
Table 125. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Roche Latest Developments
Table 127. Remedium Bio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 128. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 129. Remedium Bio Main Business
Table 130. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Remedium Bio Latest Developments
LIST OF FIGURES
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adeno-Associated Virus (AAV) Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Adeno-Associated Virus (AAV) Gene Therapy in Central Nervous System Diseases
Figure 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Central Nervous System Diseases (2018-2023) & ($ Millions)
Figure 12. Adeno-Associated Virus (AAV) Gene Therapy in Ocular Diseases
Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Ocular Diseases (2018-2023) & ($ Millions)
Figure 14. Adeno-Associated Virus (AAV) Gene Therapy in Liver-directed Diseases
Figure 15. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Liver-directed Diseases (2018-2023) & ($ Millions)
Figure 16. Adeno-Associated Virus (AAV) Gene Therapy in Other Hereditary Diseases
Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Other Hereditary Diseases (2018-2023) & ($ Millions)
Figure 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player in 2022
Figure 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Value Market Share by Country in 2022
Figure 26. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2022
Figure 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 33. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2022
Figure 40. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. China Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. India Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. France Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adeno-Associated Virus (AAV) Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Adeno-Associated Virus (AAV) Gene Therapy in Central Nervous System Diseases
Figure 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Central Nervous System Diseases (2018-2023) & ($ Millions)
Figure 12. Adeno-Associated Virus (AAV) Gene Therapy in Ocular Diseases
Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Ocular Diseases (2018-2023) & ($ Millions)
Figure 14. Adeno-Associated Virus (AAV) Gene Therapy in Liver-directed Diseases
Figure 15. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Liver-directed Diseases (2018-2023) & ($ Millions)
Figure 16. Adeno-Associated Virus (AAV) Gene Therapy in Other Hereditary Diseases
Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Other Hereditary Diseases (2018-2023) & ($ Millions)
Figure 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player in 2022
Figure 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Value Market Share by Country in 2022
Figure 26. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2022
Figure 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 33. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2022
Figure 40. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. China Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. India Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. France Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
